cilazapril, anhydrous has been researched along with Nephrotic Syndrome in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Basal, S; Caglar, K; Eyileten, T; Ipcioglu, OM; Kaya, A; Korkmaz, A; Oguz, Y; Sonmez, A; Topal, T; Vural, A; Yenicesu, M; Yilmaz, MI | 1 |
1 other study(ies) available for cilazapril, anhydrous and Nephrotic Syndrome
Article | Year |
---|---|
Hyperbaric oxygen treatment augments the efficacy of cilazapril and simvastatin regimens in an experimental nephrotic syndrome model.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antioxidants; Cilazapril; Combined Modality Therapy; Disease Models, Animal; Doxorubicin; Glutathione Peroxidase; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperbaric Oxygenation; Kidney; Male; Nephrotic Syndrome; Oxidative Stress; Protein Carbonylation; Proteinuria; Rats; Rats, Sprague-Dawley; Simvastatin; Superoxide Dismutase | 2008 |